General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0SMTQN
ADC Name
MG-2002A
Synonyms
MG 2002A; MG-2002A; MG2002A
   Click to Show/Hide
Organization
Shanghai MabGen Biotech Ltd; Shanghai Meijing Science & Technology Co. Ltd.
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Tumor
Phase 1
Company Pipeline
Drug-to-Antibody Ratio
Undisclosed
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
Undisclosed
Linker Name
Undisclosed
Conjugate Type
Undisclosed